STRONGBRIDGE BIOPHARMA plc Retained Earnings
STRONGBRIDGE BIOPHARMA plc had Retained Earnings of -$330.61 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-08-05
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$330.61M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$317.37M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$305.56M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$293.61M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-06-30 | -$330.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$317.37M 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$305.56M 10-Q · filed 2021-08-05 |
| 2020-09-30 | -$293.61M 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$290.45M 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$273.18M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$260.48M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$251.50M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$237.71M 10-Q · filed 2019-07-31 |
| 2019-03-31 | -$229.47M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$211.03M 10-K · filed 2020-02-28 |
| 2018-09-30 | -$295.09M 10-Q · filed 2018-10-31 |
| 2018-06-30 | -$274.53M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$271.61M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$242.88M 10-K · filed 2019-02-27 |
| 2017-09-30 | -$224.13M 6-K · filed 2017-11-14 |
| 2017-06-30 | -$189.07M 6-K · filed 2017-08-07 |
| 2017-03-31 | -$158.88M 6-K · filed 2017-05-16 |
| 2016-12-31 | -$129.40M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$113.40M 6-K · filed 2016-12-30 |
| 2016-06-30 | -$105.80M 6-K · filed 2016-12-30 |
| 2016-03-31 | -$92.96M 6-K · filed 2016-05-17 |
| 2015-12-31 | -$80.80M 20-F · filed 2017-04-04 |
| 2014-12-31 | -$37.22M 20-F · filed 2016-03-24 |